BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 192171)

  • 1. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
    Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
    Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of watery diarrhea, hypokalemia and hypercalcemia associated with nonulcerogenic islet cell tumor of the pancreas.
    Hirose S; Kobayashi K; Kajikawa K; Sawabu N
    Am J Gastroenterol; 1975 Nov; 64(5):382-91. PubMed ID: 174423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
    Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
    Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
    Namihira Y; Achord JL; Subramony C
    Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
    Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
    Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
    Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
    Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
    Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of gut hormone-producing tumors (author's transl)].
    Yamaguchi K; Abe K
    Horumon To Rinsho; 1979; 27(12):1363-78. PubMed ID: 44490
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
    Wynick D; Williams SJ; Bloom SR
    N Engl J Med; 1988 Sep; 319(10):605-7. PubMed ID: 2842676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
    Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
    Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of diarrhea and WDHA syndrome].
    Ozawa Y; Shishiba Y
    Nihon Rinsho; 1982; 40(5):1151-7. PubMed ID: 6288980
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carcinoma of the pancreas with hypokalemic watery diarrhea (Verner-Morrison syndrome). Presentation of a case and review of literature)].
    Pileri S; Martinelli G; Bazzocchi F; Azzaroli P; De Martinis E; Garoia C; Severi B
    Pathologica; 1979; 71(1015):641-56. PubMed ID: 233152
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.
    Asa SL; Kovacs K; Killinger DW; Marcon N; Platts M
    Am J Gastroenterol; 1980 Jul; 74(1):30-5. PubMed ID: 6107042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion.
    Ferrara JJ; Fucci JC; Benson JB
    Conn Med; 1985 Dec; 49(12):777-80. PubMed ID: 3002718
    [No Abstract]   [Full Text] [Related]  

  • 16. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of gastrointestinal hormones.
    Lamers CB
    Neth J Med; 1978; 21(2):77-82. PubMed ID: 206847
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
    Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
    Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIPomas and the watery diarrhoea syndrome.
    Modlin IM; Bloom SR
    S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
    Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
    Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.